Evidence map›Paper›PMID 31051046›Full record

ReviewBritish journal of pharmacology2020

Hydrogen sulfide and dermatological diseases.

Silvia A Coavoy-Sánchez, Soraia K P Costa, Marcelo N Muscará

Abstract readReview
In one paragraph

Review in British journal of pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Hydrogen Sulfide Metabolism in the Skin: From Physiology to Malignancy.International journal of molecular sciences · 2025
    Review
  3. Review
  4. Review
  5. Review
  6. Gas Delivery Relevant to Human Health using Porous Materials.Chemistry (Weinheim an der Bergstrasse, Germany) · 2024
    Review
  7. Article
  8. Pills of Multi-Target HInternational journal of molecular sciences · 2024
    Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. A Whiff of Sulfur: One Wind a Day Keeps the Doctor Away.Antioxidants (Basel, Switzerland) · 2022
    Review
  14. Article
  15. HBiomolecules · 2021
    Review
  16. Article
  17. Review
  18. Article
  19. Hydrogen Sulfide: a Novel Immunoinflammatory Regulator in Rheumatoid Arthritis.Advances in experimental medicine and biology · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Silvia A Coavoy-SánchezDepartment of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.ORCID 0000-0001-7198-8915
Soraia K P CostaDepartment of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Marcelo N MuscaráDepartment of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.ORCID 0000-0002-8342-5586

Funding

Brazilian National Council for Scientific and Technological Development (CNPq)British Council NI160127São Paulo Research Foundation - FAPESP 2014/24518-1São Paulo Research Foundation - FAPESP 2016/06146-5São Paulo Research Foundation - FAPESP 2017/16409-6
6 · The paper itself

Abstract

Skin diseases constitute a major health problem affecting a high proportion of the population every day and have different aetiologies that include inflammation, infections, and tumours. Hydrogen sulfide (H

Indexed as

GasotransmittersHydrogen SulfideSignal TransductionGasotransmittersHydrogen Sulfide

Identifiers

PMID31051046
PMCPMC7024707

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.